Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of June 24, 2024
Manage episode 425902114 series 3560281
In this edition, extensive psoriasis and IBD history predict difficult-to-treat psoriatic arthritis, targeted therapies demonstrate low risk for serious infection and more. Read the full coverage here:
Extensive psoriasis, IBD history predict difficult-to-treat psoriatic arthritis
Targeted psoriatic arthritis therapies demonstrate low risk for serious infection
VIDEO: Dermatologists, rheumatologists share care in psoriasis, psoriatic arthritis
Patients with arthritis at higher risk for poor nutrition regardless of function
FDA approves Rinvoq for JIA, psoriatic arthritis in children aged 2 years and older
References:
Bastard L, et al. RMD Open. 2024;doi:10.1136/rmdopen-2023-003865.
Bennett R, et al. Sci Rep. 2024;doi:10.1038/s41598-024-58370-7.
Husni ME. Update in the treatment of psoriatic arthritis. Presented at: Medical Dermatology Therapy Update III; May 29-31, 2024; Cleveland.
Vassilakis KD, et al. Rheumatology. 2024;doi:10.1093/rheumatology/keae263.
118 episode